Our News on Newswise

Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T Patients

In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers identify possible factors that could help physicians know if patients are at higher risk for severe adverse events before they receive CAR T therapy.
15-Jul-2020 10:40 AM EDT Add to Favorites

Moffitt Researchers Find Dual Inhibitor May Be Safer for Chronic Lymphocytic Leukemia Patients

Moffitt Cancer Center researchers want to learn more about how PI3K inhibitor therapy works with the body’s immune system to determine if there are ways to predict or mitigate associated adverse effects. Their findings were published in the July...
14-Jul-2020 9:00 AM EDT Add to Favorites

Moffitt Researchers Identify Protein that Causes Epithelial Cancers to Spread

In a new article published in the July issue of Cancer Research, Elsa Flores, Ph.D., and her team discovered a key protein that oscillates its expression through microRNA regulation to facilitate cancer spread to distant organs. This protein is...
6-Jul-2020 9:00 AM EDT Add to Favorites

Moffitt Researchers Develop Tool to Detect Patients at High Risk for Poor Lung Cancer Outcomes

In a new study published in Nature Scientific Reports, Moffitt Cancer Center researchers have shown how the use of radiomics can improve lung cancer screening by identifying early stage lung cancer patients who may be at high risk for poorer...
1-Jul-2020 10:25 AM EDT Add to Favorites

Moffitt Researchers Develop Model to Predict Prostate Cancer Aggressiveness

Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center want to better understand what is happening in the tumor microenvironment to drive prostate cancer to become aggressive and grow rapidly. In a new article...
14-May-2020 1:00 PM EDT Add to Favorites

Moffitt Cancer Center Study Suggests More Could Benefit from CAR T-Cell Therapy

Moffitt Cancer Center organized a consortium of 16 cancer treatment facilities across the U.S. that offer Yescarta as a standard-of-care therapy for patients with relapsed/refractory large B cell lymphoma. They wanted to determine if the safety and...
14-May-2020 8:30 AM EDT Add to Favorites

Newswise: JohnCleveland.jpg

Moffitt Cancer Center Appoints John Cleveland as New Center Director

Moffitt Cancer Center Appoints John Cleveland as New Center Director
29-Apr-2020 5:05 PM EDT Add to Favorites

Moffitt Researchers Identify Molecular Pathway That Controls Immunosuppression in Tumors

In a new article published in the journal Immunity, Moffitt Cancer Center researchers reveas how protein-signaling pathways associated with cellular stress processes turn myeloid cells into tumor-promoting players. They also suggest that targeting...
14-Apr-2020 11:55 AM EDT Add to Favorites


See All News

Our Experts on Newswise

CANCER AND COVID-19: Moffitt Cancer Center Experts & Resources

1-Apr-2020 8:40 AM EDT

Newswise: AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

See All Experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 50 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.5 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.

Contacts

Kim Polacek
Senior Public Relations Account Coordinator

Kim.Polacek@Moffitt.org

813-745-7408

Steven Blanchard
Public Relations Account Coordinator

Steven.Blanchard@Moffitt.org

813-745-1718

Sara Bondell
Public Relations Account Coodinator

Sara.Bondell@moffitt.org

813-745-1353

Patty Kim
Public Relations Manager

Patty.Kim@Moffitt.org

813-745-7322

Twitter

close
0.89289